Editorial Type:
Diagnostic Imaging

Hemodynamic and serum biochemical alterations associated with intravenous administration of three types of contrast media in anesthetized cats

Rachel E. Pollard Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA 95616.

Search for other papers by Rachel E. Pollard in
Current site
Google Scholar
PubMed Close
 DVM, PhD
,
Sarah M. Puchalski Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA 95616.

Search for other papers by Sarah M. Puchalski in
Current site
Google Scholar
PubMed Close
 DVM
, and
Peter J. Pascoe Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California, Davis, CA 95616.

Search for other papers by Peter J. Pascoe in
Current site
Google Scholar
PubMed Close
 BVSc
DOI:
https://doi.org/10.2460/ajvr.69.10.1274
Volume/Issue:
Volume 69: Issue 10
Online Publication Date:
01 Oct 2008
Restricted access
Sign In Reprints and Permissions Purchase Article

Abstract

Objective—To determine the incidence and type of alterations in heart rate (HR), peak systolic blood pressure (PSBP), and serum biochemical variables (serum total bilirubin, BUN, and creatinine concentrations) associated with IV administration of ionic-iodinated contrast (IIC), nonionic-iodinated contrast (NIC), and gadolinium (GD) contrast media in anesthetized cats.

Animals—220 anesthetized cats undergoing cross-sectional imaging.

Procedures—HR and PSBP were recorded at 5-minute intervals for 20 minutes for untreated control cats and cats that received IIC, NIC, or GD contrast medium. The development of HR < 100 beats/min or > 200 beats/min that included a ≥ 20% change from baseline was considered a response. The development of PSBP of < 90 mm Hg or > 170 mm Hg that included a ≥ 20% change from baseline was considered a response. Pre- and postcontrast serum biochemical values were recorded.

Results—Of cats receiving IIC medium, 2% (1/60) had a response in HR at ≥ 1 time point. Of cats receiving IIC medium, 7% (4/60) had a response in PSBP. None of the cats receiving NIC medium had a response in HR; 2 of 12 had a response in PSBP. Of cats receiving GD contrast medium, 6% (5/83) had a response in HR and 8% (7/83) had a response in PSBP. None of the control cats had a response in HR or PSBP. No serum biochemical alterations were observed.

Conclusions and Clinical Relevance—IV administration of iodine and GD contrast media in anesthetized cats was associated with changes in HR and PSBP.

Abstract

Objective—To determine the incidence and type of alterations in heart rate (HR), peak systolic blood pressure (PSBP), and serum biochemical variables (serum total bilirubin, BUN, and creatinine concentrations) associated with IV administration of ionic-iodinated contrast (IIC), nonionic-iodinated contrast (NIC), and gadolinium (GD) contrast media in anesthetized cats.

Animals—220 anesthetized cats undergoing cross-sectional imaging.

Procedures—HR and PSBP were recorded at 5-minute intervals for 20 minutes for untreated control cats and cats that received IIC, NIC, or GD contrast medium. The development of HR < 100 beats/min or > 200 beats/min that included a ≥ 20% change from baseline was considered a response. The development of PSBP of < 90 mm Hg or > 170 mm Hg that included a ≥ 20% change from baseline was considered a response. Pre- and postcontrast serum biochemical values were recorded.

Results—Of cats receiving IIC medium, 2% (1/60) had a response in HR at ≥ 1 time point. Of cats receiving IIC medium, 7% (4/60) had a response in PSBP. None of the cats receiving NIC medium had a response in HR; 2 of 12 had a response in PSBP. Of cats receiving GD contrast medium, 6% (5/83) had a response in HR and 8% (7/83) had a response in PSBP. None of the control cats had a response in HR or PSBP. No serum biochemical alterations were observed.

Conclusions and Clinical Relevance—IV administration of iodine and GD contrast media in anesthetized cats was associated with changes in HR and PSBP.

Contributor Notes

Presented in part at the Annual European Association of Veterinary Diagnostic Imaging Meeting, Thessaloniki, Greece, August 2007.

Address correspondence to Dr. Pollard.
Cover American Journal of Veterinary Research
American Journal of Veterinary Research
Publication Date:
01 Oct 2008
  • 1.

    Gueant-Rodriguez RM, Romano A, Barbaud A, et al. Hypersensitivity reactions to iodinated contrast media. Curr Pharm Des 2006;12:3359–3372.

  • 2.

    Li A, Wong CS, Wong MK, et al. Acute adverse reactions to magnetic resonance contrast media—gadolinium chelates. Br J Radiol 2006;79:368–371.

  • 3.

    Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001;11:1267–1275.

  • 4.

    Katayama H, Yamaguchi K, Kozuka T, et al. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621–628.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Morcos SK. Contrast media-induced nephrotoxicity—questions and answers. Br J Radiol 1998;71:357–365.

  • 6.

    Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol 1989;152:939–944.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Pollard RE, Puchalski SM, Pascoe PJ. Hemodynamic and serum biochemical alterations associated with intravenous administration of three types of contrast media in anesthetized dogs. Am J Vet Res 2008;69:1268–1273.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Goldstein HA, Kashanian FK, Blumetti RF, et al. Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 1990;174:17–23.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359–2362.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Kurabayashi T, Ida M, Fukayama H, et al. Adverse reactions to nonionic iodine in contrast-enhanced computed tomography: usefulness of monitoring vital signs. Dentomaxillofac Radiol 1998;27:199–202.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    DiBartola SP. Textbook of veterinary internal medicine. 6th ed. St Louis: Elsevier Saunders, 2005.

  • 12.

    Namasivayam S, Kalra MK, Torres WE, et al. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210–215.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3–9.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Pereira GG, Larsson MH, Yamaki FL, et al. Effects of propofol on the electrocardiogram and systolic blood pressure of healthy cats pre-medicated with acepromazine. Vet Anaesth Analg 2004;31:235–238.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Ansell G. Complications of intravascular iodinated contrast media. Oxford, England: Blackwell Scientific Publications, 1987.

  • 16.

    Dawson P. Cardiovascular effects of contrast agents. Am J Cardiol 1989;64:2E–9E.

  • 17.

    Dawson P, Edgerton D. Contrast media and enzyme inhibition. I. Cholinesterase. Br J Radiol 1983;56:653–656.

  • 18.

    Assem ES, Bray K, Dawson P. The release of histamine from human basophils by radiological contrast agents. Br J Radiol 1983;56:647–652.

  • 19.

    Baxter AB, Lazarus SC, Brasch RC. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. Invest Radiol 1993;28:308–312.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Kuo PH, Kanal E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647–649.

  • 21.

    Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177–182.

Advertisement